n-3 fatty acids and the metabolic syndrome.

@article{Carpentier2006n3FA,
  title={n-3 fatty acids and the metabolic syndrome.},
  author={Yvon A. Carpentier and Laurence Portois and Willy J Malaisse},
  journal={The American journal of clinical nutrition},
  year={2006},
  volume={83 6 Suppl},
  pages={
          1499S-1504S
        }
}
The metabolic syndrome is defined as the coexistence of 3 or more components, some of which indicate alterations in glucose and lipid metabolism. The prevalence of the metabolic syndrome is rapidly increasing in relation to obesity, and it is considered to be an important predictor of cardiovascular disease. Increased intakes or supplements of n-3 marine fatty acids may improve defects in insulin signaling and prevent alterations in glucose homeostasis and the further development of type 2… Expand
N-3 fatty acids in glucose metabolism and insulin sensitivity.
TLDR
The possible mechanisms through which n-3 PUFA are involved in glucose level control and insulin sensitivity are reviewed and interventions together with recent findings on the nutrigenomic field related with this subject are briefly reviewed. Expand
Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update.
TLDR
Proposed mechanisms by which n-3 PUFAs may work to improve body composition and counteract obesity-related metabolic changes include modulating lipid metabolism; regulating adipokines, such as adiponectin and leptin; alleviating adipose tissue inflammation; promoting adipogenesis and altering epigenetic mechanisms. Expand
Inflammation, obesity, and fatty acid metabolism: influence of n-3 polyunsaturated fatty acids on factors contributing to metabolic syndrome.
TLDR
Preliminary evidence is reviewed regarding the role of dietary n-3 polyunsaturated fatty acids in modulating each of the components of the triad of adiposity, inflammation, and fatty acid metabolism, with particular attention to therole of the postprandial period as a contributor to the pathophysiology of MetS. Expand
Severity of metabolic syndrome unfavorably influences oxidative stress and fatty acid metabolism in men.
TLDR
The severity of MS is connected with the progression of oxidative stress and the unfavorable changes in the FA composition, which are independent of the studied gene polymorphisms. Expand
Peroxisome proliferator-activated receptors and the metabolic syndrome
TLDR
The ability of PPARs to sense fatty acids and to mediate lipid metabolism, glucose metabolism and the inflammatory state makes them excellent targets for dietary modulation in order to prevent and treat the metabolic syndrome and associated diseases. Expand
Role of ω3 long-chain polyunsaturated fatty acids in reducing cardio-metabolic risk factors.
TLDR
It can be concluded that dietary supplementation with ω3 LC-PUFA will lead to improvements in cardio-metabolic health parameters, and these fatty acids do not interact adversely with the common drug therapies used in the management of hypertension, dyslipidemia, type-2 diabetes, and obesity/metabolic syndrome. Expand
NUTRITIONAL SUPPLEMENTS AND METABOLIC SYNDROME
TLDR
There is compelling evidence that 1.5–3 g a day of acetyl-carnitine can improve cognitive function of individuals in the milder, early stages of Alzheimer's disease, as well as many other nutritional supplements that play an important role in Metabolic Syndrome. Expand
Dietary n-3:n-6 fatty acid ratios differentially influence hormonal signature in a rodent model of metabolic syndrome relative to healthy controls
TLDR
These data are the first to demonstrate that a rodent line with a metabolic syndrome-like phenotype responds differentially to dietary manipulation of n-3 and n-6 fatty acids relative to a related healthy line with regard to endocrine markers of energy homeostasis. Expand
Chronic dietary n-3 PUFA intervention improves dyslipidaemia and subsequent cardiovascular complications in the JCR:LA- cp rat model of the metabolic syndrome.
TLDR
The chronic metabolic benefits of dietary n-3 PUFA may underlie the potential to reduce vascular complications during the MetS, including the observed reduction in the frequency of late-stage 3 myocardial lesions. Expand
Adipose tissue n-3 fatty acids and metabolic syndrome
TLDR
The results suggest that ALA could exert a modest protective benefit, whereas EPA and DHA are not implicated in MetS, and could reflect higher delta-6 desaturase activity caused by increased adiposity. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 51 REFERENCES
n-3 Polyunsaturated fatty acids, inflammation and obesity-related disease
  • L. Browning
  • Biology, Medicine
  • Proceedings of the Nutrition Society
  • 2003
TLDR
The data show that an inflammatory phenotype, measured by serum sialic acid concentration, identifies individuals with insulin resistance, dyslipidaemia and hypertension, suggesting a possible interaction between diet and phenotype. Expand
N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity?
TLDR
N-3 LC-PUFA reduces insulin response to oral glucose without altering the glycaemic response, abolishes extraggression at times of mental stress, decreases the activation of sympathetic activity during mental stress and also decreases plasma triglycerides. Expand
Kinetic studies of lipoprotein metabolism in the metabolic syndrome including effects of nutritional interventions
TLDR
The nutritional interventions discussed in this review are readily transferable into clinical preventive practice and the potential benefits to be gained by weight loss and fish oil supplementation in the metabolic syndrome extend beyond their specific and positive effects on lipoprotein metabolism. Expand
Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects.
TLDR
At estimated biologically equivalent intakes, dietary ALA and EPA+DHA have different physiologic effects. Expand
Lipid-lowering drugs and essential omega-6 and omega-3 fatty acids in patients with coronary heart disease.
TLDR
It is reported for the first time in a double-blind randomized study in CHD patients that LLDs significantly alter the metabolism of essential fatty acids that are critically important for the pathogenesis and prevention of CHD. Expand
Omega-3 fatty acids: molecular approaches to optimal biological outcomes
TLDR
This review discusses recent advances in delineating basic mechanisms whereby ω-3 fatty acids modulate cellular pathways to exert beneficial effects on promoting health and decreasing risks of certain diseases. Expand
Diabetogenic Impact of Long-Chain ω-3 Fatty Acids on Pancreatic β-Cell Function and the Regulation of Endogenous Glucose Production
TLDR
Substitution of long-chain ω-3 fatty acids for a small percentage of dietary saturated fat prevents high-saturated fat feeding-induced insulin resistance with respect to peripheral glucose disposal and reverses insulin hypersecretion in response to glucose in vivo. Expand
N-3 polyunsaturated fatty acids prevent the defect of insulin receptor signaling in muscle.
TLDR
A high-fat diet enriched in n-3 fatty acids maintained IR, IRS-1 tyrosine phosphorylation, and PI 3'-kinase activity and total GLUT-44 content in muscle but not in liver. Expand
Fish oil prevents the adrenal activation elicited by mental stress in healthy men.
TLDR
After 3 weeks of a diet supplemented with n-3 fatty acids, the stimulation by mental stress of plasma epinephrine, cortisol, energy expenditure, and plasma non esterified fatty acids concentrations were all significantly blunted. Expand
Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia.
TLDR
In visceral obesity, atorvastatin increased hepatic clearance of all apoB-containing lipoproteins, whereas fish oils decreased hepatic secretion of VLDL-apoB. Expand
...
1
2
3
4
5
...